The Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis

Elshafae, SM; Kohart, NA; Altstadt, LA; Dirksen, WP; Rosol, TJ

Rosol, TJ (reprint author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.

PROSTATE, 2017; 77 (7): 776

Abstract

BACKGROUND. Canine prostate cancer (PCa) is an excellent preclinical model for human PCa. AR-42 is a histone deacetylase inhibitor (HDACi) developed a......

Full Text Link